|Quality of life and other patient-reported outcomes following pelvic exenteration for pelvic malignancy|
JM Young, T Badgery-Parker, LM Masya, M King, C Koh, AC Lynch, ...
British Journal of Surgery, 2014
|Trends in use of neonatal CPAP: a population-based study|
CL Roberts, T Badgery-Parker, CS Algert, JR Bowen, N Nassar
BMC pediatrics 11 (1), 89, 2011
|Comparison of ECOG/WHO performance status and ASA score as a measure of functional status|
J Young, T Badgery-Parker, T Dobbins, M Jorgensen, P Gibbs, I Faragher, ...
Journal of pain and symptom management 49 (2), 258-264, 2015
|Patterns and outcomes of preterm hospital admissions during pregnancy in NSW, 2001–2008|
T Badgery‐Parker, JB Ford, MG Jenkins, JM Morris, CL Roberts
Medical journal of Australia 196 (4), 261-265, 2012
|Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut|
Y Wang, T Badgery-Parker, S Lovas, N Chartrel, H Vaudry, E Burcher, ...
Biochemical Journal 287 (3), 827-832, 1992
|Outcomes of pelvic exenteration for locally advanced primary rectal cancer: overall survival and quality of life|
AJ Quyn, KKS Austin, JM Young, T Badgery-Parker, LM Masya, R Roberts, ...
European Journal of Surgical Oncology (EJSO) 42 (6), 823-828, 2016
|Receptor binding profile of neuropeptide γ and its fragments: Comparison with the nonmammalian peptides carassin and ranakinin at three mammalian tachykinin receptors|
T Badgery-Parker, S Lovas, JM Conlon, E Burcher
Peptides 14 (4), 771-775, 1993
|Characterisation of a novel, selective radioligand,[125I][Lys5, Tyr (I2) 7, MeLeu9, Nle10] neurokinin A-(4–10), for the tachykinin NK2 receptor in rat fundus|
E Burcher, T Badgery-Parker, XP Zeng, S Lavielle
European journal of pharmacology 233 (2-3), 201-207, 1993
|Tachykinin receptors in rabbit airways—characterization by functional, autoradiographic and binding studies|
JL Black, LM Diment, LA Alouan, PRA Johnson, CL Armour, ...
British journal of pharmacology 107 (2), 429-436, 1992
|Low-value care in Australian public hospitals: prevalence and trends over time|
T Badgery-Parker, SA Pearson, K Chalmers, J Brett, IA Scott, S Dunn, ...
BMJ Qual Saf 28 (3), 205-214, 2019
|Assessing measures of comorbidity and functional status for risk adjustment to compare hospital performance for colorectal cancer surgery: a retrospective data-linkage study|
TA Dobbins, T Badgery-Parker, DC Currow, JM Young
BMC medical informatics and decision making 15 (1), 55, 2015
|Improving psychosocial outcomes for caregivers of people with poor prognosis gastrointestinal cancers: a randomized controlled trial (Family Connect)|
JM Shaw, JM Young, PN Butow, T Badgery-Parker, I Durcinoska, ...
Supportive Care in Cancer 24 (2), 585-595, 2016
|Developing indicators for measuring low-value care: mapping Choosing Wisely recommendations to hospital data|
K Chalmers, T Badgery-Parker, SA Pearson, J Brett, IA Scott, AG Elshaug
BMC research notes 11 (1), 163, 2018
|Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study|
E Tracey, B McCaughan, T Badgery-Parker, J Young, B Armstrong
Thorax 70 (2), 152-160, 2015
|A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study|
J Brett, AG Elshaug, RS Bhatia, K Chalmers, T Badgery-Parker, ...
Implementation Science 12 (1), 58, 2017
|Patients with localized non‐small cell lung cancer miss out on curative surgery with distance from specialist care|
E Tracey, B McCaughan, T Badgery‐Parker, J Young, BK Armstrong
ANZ journal of surgery 85 (9), 658-663, 2015
|Measuring hospital-acquired complications associated with low-value care|
T Badgery-Parker, SA Pearson, S Dunn, AG Elshaug
JAMA internal medicine 179 (4), 499-505, 2019
|Validation of MRI and surgical decision making to predict a complete resection in pelvic exenteration for recurrent rectal cancer|
WE Brown, CE Koh, T Badgery-Parker, MJ Solomon
Diseases of the Colon & Rectum 60 (2), 144-151, 2017
|Multifetal pregnancies: preterm admissions and outcomes|
T Badgery-Parker, AW Shand, JB Ford, MG Jenkins, JM Morris, ...
Australian Health Review 36 (4), 437-442, 2012
|A novel, selective radioligand,[125I]-[Lys5, Tyr (I2) 7, MeLeu9, Nle10]-NKA (4-10), for the tachykinin NK-2 receptor.|
T Badgery-Parker, XP Zeng, S Lavielle, E Burcher
Regulatory peptides 46 (1-2), 455, 1993